These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 1316389)
1. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. Willemsen M; De Doncker P; Willems J; Woestenborghs R; Van de Velde V; Heykants J; Van Cutsem J; Cauwenbergh G; Roseeuw D J Am Acad Dermatol; 1992 May; 26(5 Pt 1):731-5. PubMed ID: 1316389 [TBL] [Abstract][Full Text] [Related]
2. Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis. Matthieu L; De Doncker P; Cauwenbergh G; Woestenborghs R; van de Velde V; Janssen PA; Dockx P Clin Exp Dermatol; 1991 Sep; 16(5):374-6. PubMed ID: 1665402 [TBL] [Abstract][Full Text] [Related]
3. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis. Kawada A; Aragane Y; Tezuka T J Dermatol; 2004 Feb; 31(2):104-8. PubMed ID: 15160863 [TBL] [Abstract][Full Text] [Related]
5. Transungual delivery of ketoconazole using novel lacquer formulation. Hafeez F; Hui X; Chiang A; Hornby S; Maibach H Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of antifungal agents in onychomycoses. Debruyne D; Coquerel A Clin Pharmacokinet; 2001; 40(6):441-72. PubMed ID: 11475469 [TBL] [Abstract][Full Text] [Related]
7. Assay of itraconazole in nail clippings by reversed phase, high performance liquid chromatography. Badcock NR; Davies A Ann Clin Biochem; 1990 Sep; 27 ( Pt 5)():506-8. PubMed ID: 2177964 [No Abstract] [Full Text] [Related]
8. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail. Rich P; Scher RK; Breneman D; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB; Hilbert J J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S103-9. PubMed ID: 9631992 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail. Savin RC; Drake L; Babel D; Stewart DM; Rich P; Ling MR; Breneman D; Scher RK; Martin AG; Pariser DM; Pariser RJ; Ellis CN; Kang S; Friedman D; Katz HI; McDonald CJ; Muglia J; Webster G; Elewski BE; Leyden JJ; Bucko AD; Tschen EH; Hanifin JM; Morman MR; Hilbert J J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S110-6. PubMed ID: 9631993 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of itraconazole in the management of onychomycosis. Hay RJ; Clayton YM; Moore MK; Midgely G Br J Dermatol; 1988 Sep; 119(3):359-66. PubMed ID: 2846030 [TBL] [Abstract][Full Text] [Related]
12. Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison. Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T Br J Dermatol; 1999 Jan; 140(1):96-101. PubMed ID: 10215775 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole in onychomycosis. Open and double-blind studies. Walsøe I; Stangerup M; Svejgaard E Acta Derm Venereol; 1990; 70(2):137-40. PubMed ID: 1969198 [TBL] [Abstract][Full Text] [Related]
14. Itraconazole in the management of chronic dermatophytosis. Hay RJ; Clayton YM; Moore MK; Midgely G J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):561-4. PubMed ID: 2170475 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of terbinafine in the nail. Finlay AY Br J Dermatol; 1992 Feb; 126 Suppl 39():28-32. PubMed ID: 1531925 [TBL] [Abstract][Full Text] [Related]
16. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Dykes PJ; Thomas R; Finlay AY Br J Dermatol; 1990 Oct; 123(4):481-6. PubMed ID: 2151303 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. Piepponen T; Blomqvist K; Brandt H; Havu V; Hollmen A; Kohtamäki K; Lehtonen L; Turjanmaa K J Antimicrob Chemother; 1992 Feb; 29(2):195-205. PubMed ID: 1324238 [TBL] [Abstract][Full Text] [Related]
19. Nail incorporation kinetics of terbinafine in onychomycosis patients. Schatz F; Bräutigam M; Dobrowolski E; Effendy I; Haberl H; Mensing H; Weidinger G; Stütz A Clin Exp Dermatol; 1995 Sep; 20(5):377-83. PubMed ID: 8593713 [TBL] [Abstract][Full Text] [Related]
20. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers. Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]